These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 608537)

  • 1. Control of viability, thermostability and residual virulene of BCG vaccines. Multiple comparison of laboratory data to select products for immunostimulation in the treatment of cancer.
    Lugosi L
    Dev Biol Stand; 1977 Apr 13-15; 38():45-50. PubMed ID: 608537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple comparison of dried BCG vaccines: stability at 37 degrees C and persistence of strains in the mouse spleen.
    Lugosi L
    Vaccine; 1984 Jun; 2(2):149-56. PubMed ID: 6531957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical quality control methods in standardization of BCG vaccines.
    Lugosi L
    Dev Biol Stand; 1986; 58 ( Pt A)():213-27. PubMed ID: 3596031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of freeze-dried vaccines prepared from four different strains of BCG.
    Landi S; Barbara C; Przykuta K; Held HR
    Dev Biol Stand; 1977 Apr 13-15; 38():19-28. PubMed ID: 608506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guérin to molecular biology. A review.
    Lugosi L
    Tuber Lung Dis; 1992 Oct; 73(5):252-61. PubMed ID: 1493232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative persistence capacity of BCG substrains in mouse spleen. Computerized statistical analysis. Multiple comparison.
    Lugosi L
    Can J Microbiol; 1992 Mar; 38(3):165-73. PubMed ID: 1393817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of the Hungarian National BCG Reference Preparations. Trend of viability during 4-7 years storage at +4 degrees C.
    Lugosi L
    Acta Microbiol Hung; 1987; 34(1):11-8. PubMed ID: 3307276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of thermostability of lyophilized BCG vaccines by using an accelerated thermal degradation test].
    Janaszek W
    Med Dosw Mikrobiol; 1991; 43(1-2):43-9. PubMed ID: 1784137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of BCG vaccines: Polish, Danish and Japanese -- laboratory tests].
    Janaszek W
    Przegl Epidemiol; 1994; 48(3):285-92. PubMed ID: 7938633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the toxic effect on mice of a massive dose of French BCG after low, medium and high dose pretreatment of the French, Glaxo and Japan BCG strains.
    Lugosi L; Drinóczy M
    Dev Biol Stand; 1977; 34():189-91. PubMed ID: 838143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized viability test required for preventive, immunomodulator and recombinant BCG vaccine.
    Lugosi L
    Dev Biol Stand; 1992; 77():211-5. PubMed ID: 1426664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of an international collaborative study to establish the suitability of using modified ATP assay for viable count of BCG vaccine.
    Ho MM; Markey K; Rigsby P; Jensen SE; Gairola S; Seki M; Castello-Branco LR; López-Vidal Y; Knezevic I; Corbel MJ
    Vaccine; 2008 Aug; 26(36):4754-7. PubMed ID: 18586063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigations carried out to ascertain the dose-effect relationship of a BCG vaccine, strain 1331 Copenhagen, in neonates and young infants (author's transl)].
    Lehmann HG; Hennessen W; Engelhardt H; Freudenstein H; Widmark R; Weber-Oldecop H; Oehme J; Siegle-Joos H; Sinios A; Schmidt-Dohna W; Nevermann L; Beutnagel H; Schumann K; Schulz R; Kühl H; Schmöger R
    Zentralbl Bakteriol Orig B; 1978 Mar; 166(2-3):250-63. PubMed ID: 654682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vivo multiplication of 10 BCG substrains in three strains of mice: no correlation with their antitumour activity.
    Frenette M; Portelance V; Beaudet R
    Microbios; 1983; 36(145-46):173-82. PubMed ID: 6346021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilisation of BCG vaccines.
    Gheorghiu M; Lagranderie M; Balazuc AM
    Dev Biol Stand; 1996; 87():251-61. PubMed ID: 8854025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposals for quality control methods of bacterial vaccines for immunostimulation. I. General considerations.
    Sirks JL; Ruitenberg EJ
    Dev Biol Stand; 1977 Apr 13-15; 38():87-9. PubMed ID: 608552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application and examination of bioluminescent technique in the quality identification of BCG vaccines].
    An YQ
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Feb; 14(1):35-7, 63. PubMed ID: 1879009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immuno BCG Pasteur F vaccine.
    Gheorghiu M; Chambon L; Serié C; Juvin-Calmette D
    Dev Biol Stand; 1977 Apr 13-15; 38():29-37. PubMed ID: 608512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report on results of a collaborative assay of BCG vaccines organized by the International Associaton of Biological Standardization.
    Sekhuis VM; Freudenstein H; Sirks JL
    J Biol Stand; 1977; 5(2):85-109. PubMed ID: 328509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49).
    Günther JH; Frambach M; Deinert I; Brandau S; Jocham D; Böhle A
    J Urol; 1999 May; 161(5):1702-6. PubMed ID: 10210443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.